Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark A. Klein
Mark A. Klein
University of Minnesota
Immunology
Medicine
Biology
Platelet-activating factor
severe acute respiratory syndrome coronavirus 2
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma.
2021
Oncogene
Sk. Kayum Alam
Yongchang Zhang
Li Wang
Zhu Zhu
Christina E. Hernandez
Yuling Zhou
Nong Yang
Jian Lei
Xiaoyan Chen
Liang Zeng
Mark A. Klein
Luke H. Hoeppner
Show All
Source
Cite
Save
Citations (1)
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19.
2021
Clinical and Applied Thrombosis-Hemostasis
Mark A. Klein
Vinh Dao
Fatima Khan
Show All
Source
Cite
Save
Citations (0)
Utilization of the Veterans Affairs Central Cancer Registry to evaluate lung cancer outcomes
2019
Seminars in Oncology
Mark A. Klein
George S. Scaria
Apar Kishor Ganti
Show All
Source
Cite
Save
Citations (0)
Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions
2019
Advances in Protein Chemistry
Mark A. Klein
Show All
Source
Cite
Save
Citations (0)
1